{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:54:47Z","timestamp":1785704087781,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cpet.2026.06.016","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:18:58Z","timestamp":1785701938000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT in Childhood Cancers"],"prefix":"10.1016","author":[{"given":"Nivedita","family":"Kundu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangkim Chandra","family":"Khangembam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.120.254110","article-title":"SNMMI procedure standard\/EANM practice guideline on pediatric 18F-FDG PET\/CT for oncology 1.0","volume":"62","author":"Vali","year":"2021","journal-title":"J Nucl Med"},{"issue":"1094","key":"10.1016\/j.cpet.2026.06.016_bib2","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180584","article-title":"18F-FDG PET-CT in paediatric oncology: established and emerging applications","volume":"92","author":"Chambers","year":"2019","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.016_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/diagnostics13020192","article-title":"The impact of PET\/CT on paediatric oncology","volume":"13","author":"Brink","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cpet.2026.06.016_bib4","article-title":"Nuclear medicine techniques in paediatric body oncology: present and future","volume":"2","author":"Meshaka","year":"2023","journal-title":"EJC Paediatr Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.cpet.2026.06.016_bib5","article-title":"Imaging recommendations in pediatric lymphoma: a COG diagnostic imaging Committee\/SPR oncology committee white paper","volume":"70","author":"Mhlanga","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"32","key":"10.1016\/j.cpet.2026.06.016_bib6","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.16014","article-title":"Response-adapted therapy for the treatment of children with newly diagnosed high-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group","volume":"187","author":"Kelly","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00247-012-2559-z","article-title":"FDG PET\/CT in children and adolescents with lymphoma","volume":"43","author":"Kluge","year":"2013","journal-title":"Pediatr Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.016_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bjh.13219","article-title":"The role of FDG-PET\/CT in the evaluation of residual disease in paediatric Non-Hodgkin lymphoma","volume":"168","author":"Bhojwani","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.cpet.2026.06.016_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2967\/jnumed.118.222299","article-title":"Is true whole-body 18F-FDG PET\/CT required in pediatric lymphoma? An IAEA multicenter prospective study","volume":"60","author":"Cerci","year":"2019","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.016_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.semnuclmed.2016.12.004","article-title":"The role of 18F-FDG-PET\/CT in pediatric sarcoma","volume":"47","author":"Harrison","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.ro.2017.04.007","article-title":"PET\/CT of osteosarcoma and Ewing sarcoma","volume":"52","author":"Costelloe","year":"2017","journal-title":"Semin Roentgenol"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00259-011-1936-4","article-title":"Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET\/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma","volume":"39","author":"Im","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.016_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12094-015-1351-6","article-title":"Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma","volume":"18","author":"Raciborska","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.cpet.2026.06.016_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13550-020-00715-0","article-title":"[18F]FDG PET\/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial","volume":"10","author":"Polverari","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.cpet.2026.06.016_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2021.07.006","article-title":"Role of 18F-FDG-PET\/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric soft tissue sarcoma study group","volume":"155","author":"Mercolini","year":"2021","journal-title":"Eur J Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.cpet.2026.06.016_bib17","article-title":"Imaging of pediatric neuroblastoma: a COG Diagnostic Imaging Committee\/SPR Oncology Committee white paper","volume":"70","author":"Lai","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.016_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-018-4070-8","article-title":"Guidelines on nuclear medicine imaging in neuroblastoma","volume":"45","author":"Bar-Sever","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.cpet.2026.06.016_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.108.060467","article-title":"123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma","volume":"50","author":"Sharp","year":"2009","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.110.083303","article-title":"18F-FDG PET\/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis","volume":"52","author":"Papathanasiou","year":"2011","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/jpm11040270","article-title":"Nuclear medicine imaging in neuroblastoma: current status and new developments","volume":"11","author":"Samim","year":"2021","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.016_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cpet.2020.03.009","article-title":"Potential roles of total-body PET\/CT in pediatric imaging","volume":"15","author":"Nardo","year":"2020","journal-title":"Pet Clin"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2967\/jnumed.122.264112","article-title":"Optimized whole-body PET\/MRI sequence workflow in pediatric Hodgkin lymphoma patients","volume":"64","author":"Georgi","year":"2023","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00330-023-10015-5","article-title":"Comparison of diffusion-weighted MRI and 18F-FDG PET for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma","volume":"34","author":"Morakote","year":"2024","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.016_bib25","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1007\/s00330-023-10319-6","article-title":"A third of the radiotracer dose: two decades of progress in pediatric [18F]fluorodeoxyglucose PET\/CT and PET\/MR imaging","volume":"34","author":"Waelti","year":"2024","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.016_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","article-title":"Hodgkin lymphoma, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Hoppe","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.016_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.6004\/jnccn.2022.0057","article-title":"Pediatric aggressive mature B-cell lymphomas, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Barth","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib28","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0017","article-title":"Bone cancer, version 2.2025, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Biermann","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.016_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.6004\/jnccn.2024.0040","article-title":"Neuroblastoma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Bagatell","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"14","key":"10.1016\/j.cpet.2026.06.016_bib30","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.3390\/cancers14143401","article-title":"Advanced neuroimaging approaches to pediatric brain tumors","volume":"14","author":"Nikam","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.016_bib31","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"10.1016\/j.cpet.2026.06.016_bib32","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1200\/JCO.2005.02.074","article-title":"Increased fluorine-18 2-fluoro-2-deoxy-D-glucose uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography\/magnetic resonance imaging coregistration and image fusion","volume":"23","author":"Borgwardt","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.016_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.6004\/jnccn.2025.0012","article-title":"Pediatric central nervous system cancers, version 2.2025, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Gajjar","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28034","article-title":"FDG PET-CT in pediatric Langerhans cell histiocytosis","volume":"67","author":"Jessop","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.016_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00259-023-06122-6","article-title":"Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis","volume":"50","author":"Baratto","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30057","article-title":"The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging 18F-FDG PET\/CT: a retrospective study","volume":"70","author":"Rameh","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib37","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00259-020-05047-8","article-title":"18F-FDG PET\/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study","volume":"48","author":"Kirchner","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.016_bib38","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00247-017-3899-5","article-title":"The clinical impact of 18F-FDG PET\/CT in extracranial pediatric germ cell tumors","volume":"47","author":"Hart","year":"2017","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.016_bib39","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1097\/MPH.0000000000002882","article-title":"Role of 18F-fluorodeoxyglucose positron emission tomography in children with germ cell tumor after chemotherapy","volume":"46","author":"De Pasquale","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.016_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00043426-199707000-00012","article-title":"PET FDG studies of Wilms tumors","volume":"19","author":"Shulkin","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.016_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MPH.0000000000000323","article-title":"Use of 18F-FDG-PET-CT for assessment of response to neoadjuvant chemotherapy in children with Wilms tumor","volume":"37","author":"Qin","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.016_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00247-011-2201-5","article-title":"Guidelines for imaging retinoblastoma: imaging principles and MRI standardization","volume":"42","author":"de Graaf","year":"2012","journal-title":"Pediatr Radiol"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:19:03Z","timestamp":1785701943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S1556859826000696"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.06.016","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-FDG PET\/CT in Childhood Cancers","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}